Background Statins are guidelines recommended in patients with peripheral artery disease
(PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the …

Aims Due to a high burden of systemic cardiovascular events, current guidelines
recommend the use of statins in all patients with peripheral artery disease (PAD). We sought …

Objective To investigate and analyse the existing evidence supporting statin therapy in
patients with lower limb atherosclerotic arterial disease. Methods A systematic search of …

Background: Peripheral artery disease (PAD) affects more than 202 million people
worldwide. Several studies have shown that patients with PAD are often undertreated, and …

Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients
with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In …

Background: Statin dose guidelines for patients with peripheral artery disease (PAD) are
largely based on coronary artery disease and stroke data. The aim of this study is to …

High-intensity statins are recommended for patients with peripheral artery disease (PAD).
Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins …

Background Statins are recommended for use in patients with peripheral arterial disease
(PAD) to reduce cardiovascular events and mortality. However, much of the data regarding …

Background Statin use is recommended in all patients with peripheral arterial disease (PAD)
owing to its morbidity and mortality benefits. However, the effect of statin use on limb salvage …

Peripheral arterial disease (PAD) is a common condition associated with an increased risk
of coronary heart disease, myocardial infarction and stroke. It follows that PAD merits …